News

Gossamer Bio's seralutinib shows promise in PAH Phase 2 trials, but Phase 3 success is vital amidst competition. Click to ...
When it comes to ultralight backpacking, every gram counts. That’s why I was eager to test the Gossamer Gear The One – a single-skin trekking pole tent that promises big space with minimal weight.
We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other stocks under $10 that ...
Gossamer Bio (NASDAQ:GOSS – Free Report) had its target price cut by The Goldman Sachs Group from $8.00 to $7.00 in a research report sent to investors on Thursday,Benzinga reports.They ...
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of ...